Optimising Brain Metastases Management in Resource-Limited Settings: Experience with Hypofractionated Stereotactic Radiotherapy at the Salah Azaiez Institute

##plugins.themes.academic_pro.article.sidebar##

Published Feb 15, 2026
https://doi.org/10.62438/tunismed.v103i12.6125
Download
PDF
Vol. 103 No. 12 (2025): Tunis Med Dec 2025

##plugins.themes.academic_pro.article.main##

Hadhemi Ayadi
Department of Radiation Oncology,Salah Azaiez Institute,Faculty of Medicine of Tunis, University of Tunis El Manar, 1007 Tunis, Tunisia.
Alia Mousli
Department of Radiation Oncology,Salah Azaiez Institute,Faculty of Medicine of Tunis, University of Tunis El Manar, 1007 Tunis, Tunisia
Nejla Attia
Department of Radiation Oncology,Salah Azaiez Institute, Faculty of Medicine of Tunis, University of Tunis El Manar, 1007 Tunis, Tunisia
Asma Ghorbel
Department of Radiation Oncology,Salah Azaiez Institute, Faculty of Medicine of Tunis, University of Tunis El Manar, 1007 Tunis, Tunisia
Khadija Ben Zid
Department of Radiation Oncology,Salah Azaiez Institute, Faculty of Medicine of Tunis, University of Tunis El Manar, 1007 Tunis, Tunisia
Amani Yousfi
Department of Radiation Oncology,Salah Azaiez Institute, Faculty of Medicine of Tunis, University of Tunis El Manar, 1007 Tunis, Tunisia
Lotfi Ben Salem
Department of Radiation Oncology,Salah Azaiez Institute, Faculty of Medicine of Tunis, University of Tunis El Manar, 1007 Tunis, Tunisia
Mounir Besbes
Department of Radiation Oncology,Salah Azaiez Institute, Faculty of Medicine of Tunis, University of Tunis El Manar, 1007 Tunis, Tunisia
Khalil Mhajoubi
Department of Radiation Oncology,Salah Azaiez Institute, Faculty of Medicine of Tunis, University of Tunis El Manar, 1007 Tunis, Tunisia
Safia Yahyaoui
Department of Radiation Oncology,Salah Azaiez Institute, Faculty of Medicine of Tunis, University of Tunis El Manar, 1007 Tunis, Tunisia
Samia Zaraa
Department of Radiation Oncology,Salah Azaiez Institute, Faculty of Medicine of Tunis, University of Tunis El Manar, 1007 Tunis, Tunisia
Rim Abidi
Department of Radiation Oncology,Salah Azaiez Institute, Faculty of Medicine of Tunis, University of Tunis El Manar, 1007 Tunis, Tunisia
Chiraz Naser
Department of Radiation Oncology,Salah Azaiez Institute, Faculty of Medicine of Tunis, University of Tunis El Manar, 1007 Tunis, Tunisia

Abstract

Introduction: Radiotherapy remains a cornerstone in the palliative management of brain metastases (BM), a highly technical and evolving fieldtreatment is increasingly personalized. Stereotactic radiotherapy (SRT) has emerged as a precise and effective alternative to whole-brain radiotherapy (WBRT), offering better neurocognitive preservation and improved local control. This study aims to evaluate the efficacy and tolerance of SRT in the management of BM at the Salah Azaiez Institute.


Methodology: We conducted a single-center, retrospective, analyticalstudy in the radiotherapy department of the Salah Azaiez Institute between 2015 and 2022. Treatment planning was performed using the iPlan (BrainLab) and Eclipse (Varian) systems, utilizing the Conical Cone and AAA 13.7 algorithms, respectively. Techniques such as Dynamic Conformal Arc (DCA) and Volumetric Modulated Arc Therapy (VMAT) were employed. The ClinaciX (Varian), equipped with a Multi-Leaf Collimator (MLC), enabled precise beam modulation. Hypofractionated SRT was administered in three fractions of 9 Gy or five fractions of 5–6 Gy at the 80% isodose line depending of the lesion volume and site.


Results:A total of 45 patients (25 men, 20 women; median age: 57 years) were included. The primary tumors were predominantly bronchopulmonary carcinoma (60%) and breast cancer (17.8%). Solitary BM was observed in 66.6% of cases, while 33.4% had 2–3 lesions. BM presented synchronously in 35.5% and metachronously in 64.5% of cases. Two patients (4.44%) had prior prophylactic cranial irradiation for small-cell lung cancer. BM were treated in situ in 66.7% of cases. In the remaining 33.3%, stereotactic radiotherapy was performed....( abstract truncated at 250 words).

Keywords:

Stereotactic, Whole brain radiation therapy, Brain metastases

##plugins.themes.academic_pro.article.details##

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

References

  1. Sacks P, Rahman M. Epidemiology of Brain Metastases. Neurosurg Clin N Am. oct 2020;31(4):481‑8.
  2. Nayak L, Lee EQ, Wen PY. Epidemiology of brain metastases. Curr Oncol Rep. févr 2012;14(1):48‑54.
  3. Hügel M, Stöhr J, Kuhnt T, Nägler F, Papsdorf K, Klagges S, et al. Long-term survival in patients with brain metastases-clinical characterization of a rare scenario. Strahlenther Onkol Organ Dtsch Rontgengesellschaft Al. avr 2024;200(4):335‑45.
  4. Mahajan A, Ahmed S, McAleer MF, Weinberg JS, Li J, Brown P, et al. Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial. Lancet Oncol. août 2017;18(8):1040‑8.
  5. Brown PD, Ballman KV, Cerhan JH, Anderson SK, Carrero XW, Whitton AC, et al. Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC•3): a multicentre, randomised, controlled, phase 3 trial. Lancet Oncol. août 2017;18(8):1049‑60.
  6. Sperduto PW, Yang TJ, Beal K, Pan H, Brown PD, Bangdiwala A, et al. Estimating Survival in Patients With Lung Cancer and Brain Metastases: An Update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA). JAMA Oncol. 1 juin 2017;3(6):827‑31.
  7. Minniti G, D’Angelillo RM, Scaringi C, Trodella LE, Clarke E, Matteucci P, et al. Fractionated stereotactic radiosurgery for patients with brain metastases. J Neurooncol. avr 2014;117(2):295‑301.
  8. Soltys SG, Adler JR, Lipani JD, Jackson PS, Choi CYH, Puataweepong P, et al. Stereotactic radiosurgery of the postoperative resection cavity for brain metastases. Int J Radiat Oncol Biol Phys. 1 janv 2008;70(1):187‑93.
  9. Kano H, Kondziolka D, Lobato-Polo J, Zorro O, Flickinger JC, Lunsford LD. T1/T2 matching to differentiate tumor growth from radiation effects after stereotactic radiosurgery. Neurosurgery. mars 2010;66(3):486‑91; discussion 491-492.
  10. Ali MA, Hirshman BR, Wilson B, Schupper AJ, Joshi R, Proudfoot JA, et al. Improving the Prognostic Value of Disease-Specific Graded Prognostic Assessment Model for Renal Cell Carcinoma by Incorporation of Cumulative Intracranial Tumor Volume. World Neurosurg. déc 2017;108:151‑6.
  11. Hirshman BR, Wilson BR, Ali MA, Schupper AJ, Proudfoot JA, Goetsch SJ, et al. Cumulative Intracranial Tumor Volume Augments the Prognostic Value of Diagnosis-Specific Graded Prognostic Assessment Model for Survival in Patients with Melanoma Cerebral Metastases. Neurosurgery. 1 août 2018;83(2):237‑44.
  12. Shaw E, Scott C, Souhami L, Dinapoli R, Kline R, Loeffler J, et al. Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05. Int J Radiat Oncol Biol Phys. 1 mai 2000;47(2):291‑8.
  13. Minniti G, Scaringi C, Paolini S, Lanzetta G, Romano A, Cicone F, et al. Single-Fraction Versus Multifraction (3 × 9 Gy) Stereotactic Radiosurgery for Large (>2 cm) Brain Metastases: A Comparative Analysis of Local Control and Risk of Radiation-Induced Brain Necrosis. Int J Radiat Oncol Biol Phys. 15 juill 2016;95(4):1142‑8.
  14. Mousli A, Bihin B, Gustin T, Koerts G, Mouchamps M, Daisne JF. Surgical bed stereotactic radiotherapy of brain metastases: Clinical outcome and predictors of local and distant brain failure. Cancer Radiother J Soc Francaise Radiother Oncol. juill 2020;24(4):298‑305.
  15. Martinage G, Geffrelot J, Stefan D, Bogart E, Rault E, Reyns N, et al. Efficacy and Tolerance of Post-operative Hypo-Fractionated Stereotactic Radiotherapy in a Large Series of Patients With Brain Metastases. Front Oncol. 2019;9:184.
  16. Noel G, Keller A, Antoni D. [Stereotactic radiotherapy of brain metastases in complex situations]. Cancer Radiother J Soc Francaise Radiother Oncol. oct 2019;23(6‑7):708‑15.
  17. Soliman H, Ruschin M, Angelov L, Brown PD, Chiang VLS, Kirkpatrick JP, et al. Consensus Contouring Guidelines for Postoperative Completely Resected Cavity Stereotactic Radiosurgery for Brain Metastases. Int J Radiat Oncol Biol Phys. 1 févr 2018;100(2):436‑42.
  18. Farris M, McTyre ER, Cramer CK, Hughes R, Randolph DM, Ayala-Peacock DN, et al. Brain Metastasis Velocity: A Novel Prognostic Metric Predictive of Overall Survival and Freedom From Whole-Brain Radiation Therapy After Distant Brain Failure Following Upfront Radiosurgery Alone. Int J Radiat Oncol Biol Phys. 1 mai 2017;98(1):131‑41.
  19. Tallet AV, Dhermain F, Le Rhun E, Noël G, Kirova YM. Combined irradiation and targeted therapy or immune checkpoint blockade in brain metastases: toxicities and efficacy. Ann Oncol Off J Eur Soc Med Oncol. 1 déc 2017;28(12):2962‑76.
  20. Mousli A, Bihin B, Gustin T, Koerts G, Mouchamps M, Daisne JF. Application of a multi-institutional nomogram predicting salvage whole brain radiation-free survival to patients treated with postoperative stereotactic radiotherapy for brain metastases. Cancer Radiother J Soc Francaise Radiother Oncol. avr 2021;25(2):141‑6.
  21. Gorovets D, Ayala-Peacock D, Tybor DJ, Rava P, Ebner D, Cielo D, et al. Multi-institutional Nomogram Predicting Survival Free From Salvage Whole Brain Radiation After Radiosurgery in Patients With Brain Metastases. Int J Radiat Oncol Biol Phys. 1 févr 2017;97(2):246‑53.